July 22, 2013
British drug company GlaxoSmithKline is under investigation for claims its employees bribed doctors in China, as the president of its Asia-Pacific branch admitted executives “appear” to have broken the law.
Police say the company’s employees used travel agencies and consulting firms to hide a total of 3 billion yuan (£320 million), allowing them to evade GlaxoSmithKline’s internal anti-bribery controls. Investigators could not confirm how much of the funds had been paid to doctors.
The police ministry has said four employees of GSK’s China unit, including a vice president, have been detained. The company says its finance director for China was not among them, but has been barred from leaving the country.